stars 1 stars 2 stars 3

OrthoRegen offers innovative, non-surgical regenerative medicine procedures such as Super-Concentrated Platelet-Rich Plasma (PRP), Orthokine, Platelet Lysate, Prolotherapy, Perineural Injection, Musculoskeletal Shockwave Therapy, Bone Marrow Stem Cell Therapy and more for the treatment of tendinopathies, osteoarthritis and other orthopaedic conditions.

OrthoRegen Questions

The OrthoRegen annual revenue was $3 million in 2026.

OrthoRegen is based in Brisbane, Queensland.

The NAICS codes for OrthoRegen are [62111, 62, 621111, 621, 6211].

The SIC codes for OrthoRegen are [80, 801].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users